Re: Measurement of chimerism after hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 3, 2002, Pages 170-

  Woodard, Paul ^a   Cunninghman, John M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A; HEMOGLOBIN S; MYELOABLATIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BETA THALASSEMIA; CHIMERA; CONTROLLED STUDY; DONOR; ELECTROPHORESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; SIBLING; SICKLE CELL ANEMIA; VARIABLE NUMBER OF TANDEM REPEAT; GENETICS; HISTOCOMPATIBILITY; NOTE; STANDARD; STEM CELL TRANSPLANTATION; TANDEM REPEAT;

ANEMIA, SICKLE CELL; HUMANS; STEM CELL TRANSPLANTATION; TANDEM REPEAT SEQUENCES; TRANSPLANTATION CHIMERA;

EID: 0036209012     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.abbmt080170     Document Type: Letter

References (3)

1. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 tandem meetings
2. Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia
3. Functional requirements for phenotypic correction of murine β-thalassemia: Implications for human gene therapy